We are a fully integrated pure-play biologics Contract Development and Manufacturing Organization (CDMO), offering the complete spectrum of services, from cell line technology transfer to clinical and commercial manufacturing with capabilities to convert drug substance into stable formulations and fill and finish formats. We have proven technical expertise in microbial, mammalian, viral vectors, and various other technology platforms with world-class cGMP manufacturing facilities that offer high-quality services for your global programs.

Alzheimer’s disease (AD) currently afflicts nearly seven million people in the U.S. With this number expected to grow to nearly 13 million by 2050, the lack of meaningful therapies represents a major unmet medical need. Scientists at Sanford Burnham Prebys have now identified promising real-world links between common HIV drugs and a reduced incidence of AD. The study, led by Jerold Chun, M.D., Ph.D., was published in Pharmaceuticals.

A recent breakthrough study from the lab of Tanya Kalin, MD, PhD, professor of Child Health and Internal Medicine at the University of Arizona College of Medicine – Phoenix, has shown potential to improve therapeutic outcomes for patients suffering from lung cancers.

“We have identified the novel protein FOXF1 that stabilizes blood vessels inside the lung tumors, decreases intertumoral hypoxia and prevents lung cancer metastases,” explained Dr. Kalin, the senior author on this study.

GSK plc announced that the US Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for its 5-in-1 meningococcal ABCWY (MenABCWY) vaccine candidate. The Prescription Drug User Fee Act (PDUFA) action date for a regulatory decision by the US FDA on this application is 14 February 2025.

Dr Javier Díez-Domingo, Principal Investigator, FISABIO (Foundation for the Promotion of Health and Biomedical Research of the Valencian Community, Spain) said: “These final data demonstrate continued protection over more than a decade with high efficacy maintained in both the 50+ and 70+ age groups.

Eli Lilly and Company announced positive topline results of the SURMOUNT-OSA phase 3 clinical trials that showed tirzepatide injection (10 mg or 15 mg) significantly reduced the apnea-hypopnea index (AHI) compared to placebo, achieving the primary endpoints. Percentage change in AHI was a key secondary endpoint in both studies. AHI records the number of times a person's breathing shows a restricted or complete block of airflow per hour of sleep and is used to evaluate the severity of obstructive sleep apnea (OSA) and the effectiveness of treatment outcomes.

The ECHS Central Organisation is located at Delhi and functions under the Chief of Staff Committee (COSC) through AG and DGDC&W in Army HQ. The Central organisation is headed by Managing Director, ECHS, a serving Major General. There are 28 Regional Centres ECHS and 426 ECHS Polyclinics. ECHS is also an attached office of Dept of Ex-Servivemen Welfare (DoESW), Ministry of Defence (MoD) as are Directorate General Resettlement(DGR) and Kendriya Sainik Board (KSB).

Post : Pharmacist

Biotechnology Industry Research Assistance Council (BIRAC) is a not-for-profit Section 8, Schedule B, Public Sector Enterprise, under Department of Biotechnology (DBT), Government of India as an Interface Agency to strengthen and empower the emerging Biotech enterprise to undertake strategic research and innovation, addressing nationally relevant product development needs.

The Ministry of Health and Family welfare, Department of AYUSH, Government of India has approved National AYUSH Mission (NAM) as a Centrally Sponsored Scheme (CSS) to enhance AYUSH Health Services, Education, Quality of Drugs etc. And also notified vide Gazette notification number S.O.2535 (E) dated 29/09/2014.

Post : Pharmacist

CSIR - Institute of Genomics & Integrative Biology (IGIB) is a premier Institute of Council of Scientific and Industrial Research (CSIR), engaged in research of national importance in the areas of genomics, molecular medicine, bioinformatics, proteomics and environmental biotechnology.

Post : Project Associate-II

The mandate of the Institute is to address the reproductive health issues of national and global relevance. The institute was established with an objective to develop novel and efficacious modalities for fertility regulation through research and thereby assist the government in its mission to stem the population boom. In the past four decades, however, the institute has grown beyond the mandate with which it was entrusted at the time of its genesis.

MSN Group is the fastest growing research-based pharmaceutical company based out of India. Founded in 2003 with a mission to make health care affordable, this Hyderabad-based venture has nine API and five finished dosage facilities established across Hyderabad, USA and Myanmar. Innovation and speed form the crux of our business strategy.

Post : Research & Development Executive

Experience : 1-5 Years
Qualification : M.Sc | Organic Chemistry

CSIR - Institute of Genomics & Integrative Biology (IGIB) is a premier Institute of Council of Scientific and Industrial Research (CSIR), engaged in research of national importance in the areas of genomics, molecular medicine, bioinformatics, proteomics and environmental biotechnology.

Post : Project Associate-II

Hetero Drugs is an Indian pharmaceutical company and the world’s largest producer of anti-retroviral drugs. Hetero’s business includes APIs, generics, biosimilars, custom pharmaceutical services, and branded generics. Globally renowned, vertically integrated pharmaceutical player engaged in Research and Development (R&D), manufacturing, and marketing of high-quality chemical and biologic medicines across diverse therapeutic areas.

Walk-in interviews For freshers

Alkem Laboratories Limited established in 1973, is amongst the top five leading Indian Pharmaceutical Companies with global operations, engaged in the development, manufacturing and sale of Pharmaceutical and Nutraceutical Products, which are marketed in India and 50 countries internationally, primarily in the United States.

WALK IN INTERVIEW for Formulation Manufacturing Facility based at Baddi, Himachal Pradesh

Biozenta Lifescience established in 2018 with a deep emphasis to serve humanity through Quality medicaments with a vision of Human Helping Humans. Biozenta is a Research and innovation-driven pharmaceutical company with a strong impression in critical care lifesaving products specifically in Oncology, Nephro, Anti-diabetic, External preparations, and a General range of Injectables with a global market presence.

Teva is a global pharmaceutical leader and the world's largest generic medicines producer, committed to improving health and increasing access to quality health solutions worldwide.

Post : Senior Manager Facility

The Chung research group focuses on drug delivery and gene therapy, nanomedicine, and biomaterials to generate strategies to address the limitations of clinical solutions. A major focus of our work is regarding rare and genetic diseases. In particular, we are interested in biomimetic nanoparticles that can be designed to cross biological barriers and deliver molecular signals to report back on or influence the behavior of diseased tissue.

National Institute of Pharmaceutical Education and Research (NIPER), Guwahati is an Institute of National Importance set up by an Act of Parliament under the aegis of Dept. of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Govt. of India, to impart higher education and undertake advanced research in the field of Pharmaceutical Sciences and Technology. NIPER-G desires to recruit Teaching & Non-Teaching posts for the institute in the department as detailed below.

Post : Pharmacist